IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Sandoz Pty Ltd v Euro-Celtique S.A. [2013] APO 54
Patent Application: 2004229058
Title:Controlled Release Formulation
Patent Applicant: EURO-CELTIQUE S.A.
Opponent: Sandoz Pty. Ltd
Delegate: Dr B. Akhurst
Decision Date: 27 September 2013
Hearing Date: 12 June 2013, in Canberra
Catchwords: PATENTS - section 59 – opposition to grant of a patent – novelty – whether therapeutic effect disclosed – inventive step – whether the starting point can include matters outside the common general knowledge – manner of manufacture – whether a new pharmaceutical preparation is a manner of manufacture if prepared using known formulation principles – utility – whether a pharmaceutical preparation defined by its therapeutic effectiveness can lack utility –– clarity – inconsistency between elements of a dependent claim requirement for therapeutic effectiveness argued –best method – no better method identified – opposition fails on all grounds
Representation: Patent applicant: Katrina Howard of Counsel, instructed by Dr Richard Grant and Shahnaz Irani of Spruson & Ferguson, Sydney
Opponent:Andrew Fox of Counsel, instructed by Rebekah Gay of Shelston IP, Sydney
IP AUSTRALIA
AUSTRALIAN PATENT OFFICE
Patent Application: 2004229058
Title:Controlled Release Formulation
Patent Applicant: EURO-CELTIQUE S.A.
Date of Decision: 27 September 2013
DECISION
The opposition fails on all grounds. Costs according to Schedule 8 awarded against Sandoz Pty. Ltd.
REASONS FOR DECISION
Background
Patent application 2004229058 by EURO-CELTIQUE S.A. (Euroceltique) is the last of a series of divisional applications, claiming an earliest priority date of 10 May 1993. The original application 61963/94 and two serial divisionals, 39957/97 and 65526/99, lapsed without gaining acceptance. The subsequent divisional application 2002300863 was filed on 4 September 2002 and accepted on 24 September 2004. An opposition to grant of a patent was filed by Hexal Australia Pty Ltd, later amended to Sandoz Pty Ltd (Sandoz). That opposition was heard on 12 August 2008.
Application 2004229058, the subject of this opposition, was filed as a divisional of 2002300863 on 11 November 2004. After examination, it was advertised as accepted on 1 March 2007. Sandoz filed a notice of opposition on 1 June 2007 and served the statement of grounds and particulars on 31 August 2007. A request to amend the statement was allowed unopposed on 16 March 2013.
After extensions were granted for each evidentiary stage, service of evidence in support was completed on 27 November 2008, evidence in answer on 29 August 2011 and evidence in reply on 20 December 2012. Sandoz’s evidence in support consisted of declarations by:
·Ivan Alexander Rajkovic dated 30 November 2007 (IAR)
- Phillip Andrew Marshall dated 17 May 2006 (PAM)
- James Steven Rowe dated 21 October 2005 (JSR#1)
- James Steven Rowe dated 13 April 2006 (JSR#2)
- James Steven Rowe dated 27 November 2007 (JSR#3)
·James Steven Rowe dated 26 November 2008 (JSR#4)
Exhibited to JSR#3 in this opposition, the JSR#1 and JSR#2 declarations were originally filed as evidence in the opposition to grant of patent application 2002300863.
Euroceltique’s evidence in answer consisted of declarations by:
- Andrew Alexander Somogyi dated 19 April…
Keep reading for free
Create a free CaseChat account to read Sandoz Pty Ltd v Euro-Celtique S.A and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2013] APO 54
- Decision Date
CaseChat Overview and Summary
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.